Search hospitals > Iowa > Ames
Mary Greeley Medical Center
Claim this profileAmes, Iowa 50010
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
209 reported clinical trials
2 medical researchers
Summary
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 370 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Debra M. ProwMcFarland Clinic PC - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
125 reported clinical trials
185 drugs studied
Joseph J. MerchantMcFarland Clinic - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
83 reported clinical trials
134 drugs studied
Clinical Trials running at Mary Greeley Medical Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Melanoma
Cutaneous Melanoma
Renal Cell Carcinoma
Squamous Cell Carcinoma
Gastroesophageal Junction Adenocarcinoma
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mary Greeley Medical Center?
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 370 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.